Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 10 studies | 37% ± 15% | |
adipocyte | 8 studies | 30% ± 8% | |
cardiac muscle cell | 5 studies | 29% ± 4% | |
oligodendrocyte precursor cell | 4 studies | 27% ± 10% | |
neuron | 3 studies | 24% ± 6% | |
endothelial cell | 3 studies | 22% ± 5% | |
GABAergic neuron | 3 studies | 39% ± 6% | |
glutamatergic neuron | 3 studies | 51% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 36% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 10089.76 | 2641 / 2642 | 100% | 69.02 | 704 / 705 |
thymus | 99% | 4044.91 | 649 / 653 | 97% | 24.69 | 585 / 605 |
adrenal gland | 100% | 9048.38 | 258 / 258 | 95% | 21.88 | 218 / 230 |
breast | 99% | 6628.47 | 455 / 459 | 94% | 20.79 | 1050 / 1118 |
kidney | 96% | 3063.20 | 85 / 89 | 95% | 28.55 | 857 / 901 |
ovary | 100% | 6768.57 | 180 / 180 | 84% | 13.10 | 361 / 430 |
lung | 95% | 2675.31 | 549 / 578 | 79% | 9.76 | 912 / 1155 |
uterus | 98% | 3569.23 | 166 / 170 | 71% | 13.60 | 327 / 459 |
skin | 65% | 1994.94 | 1175 / 1809 | 98% | 38.16 | 464 / 472 |
prostate | 79% | 2243.04 | 193 / 245 | 83% | 8.91 | 415 / 502 |
bladder | 81% | 4015.05 | 17 / 21 | 60% | 7.51 | 300 / 504 |
esophagus | 63% | 2178.92 | 908 / 1445 | 48% | 6.06 | 88 / 183 |
intestine | 67% | 2120.93 | 643 / 966 | 36% | 5.80 | 189 / 527 |
adipose | 100% | 8101.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 5845.04 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 4192.01 | 1319 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 10836.77 | 833 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 17.78 | 74 / 80 |
pancreas | 2% | 40.35 | 8 / 328 | 87% | 13.63 | 155 / 178 |
stomach | 35% | 1063.99 | 127 / 359 | 52% | 6.01 | 149 / 286 |
lymph node | 0% | 0 | 0 / 0 | 79% | 9.29 | 23 / 29 |
spleen | 74% | 1542.15 | 178 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 5.83 | 28 / 45 |
liver | 3% | 44.20 | 6 / 226 | 53% | 6.48 | 214 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0005886 | Cellular component | plasma membrane |
GO_0019003 | Molecular function | GDP binding |
GO_0005525 | Molecular function | GTP binding |
GO_0030742 | Molecular function | GTP-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003925 | Molecular function | G protein activity |
GO_0003924 | Molecular function | GTPase activity |
Gene name | MRAS |
Protein name | MRAS protein (Muscle RAS oncogene homolog, isoform CRA_a) (cDNA FLJ42964 fis, clone BRSTN2013741, highly similar to Ras-related protein M-Ras) Ras-related protein M-Ras (EC 3.6.5.2) (Ras-related protein R-Ras3) Muscle RAS oncogene homolog |
Synonyms | RRAS3 hCG_17104 |
Description | FUNCTION: Serves as an important signal transducer for a novel upstream stimuli in controlling cell proliferation. Activates the MAP kinase pathway. . |
Accessions | ENST00000475711.5 C9J601 Q6FGP0 ENST00000474559.1 [O14807-1] ENST00000614350.4 [O14807-2] ENST00000621127.4 [O14807-2] ENST00000464896.5 [O14807-2] ENST00000289104.8 [O14807-1] O14807 C9J8Q6 ENST00000494949.5 ENST00000423968.7 [O14807-1] |